Table 1 Baseline characteristics of patients.
From: Isolation and characterization of microparticles in sputum from cystic fibrosis patients
| Â | Stable CF | Acute CF | p | PCD |
|---|---|---|---|---|
N | 11 | 10 | Â | 7 |
Age (years) | 23.4 ± 4.3 | 24.5 ± 3.7 |  | 22.7 ± 3.5 |
Sex ratio (male:female) | 7:4 | 2:8 | Â | 3:4 |
F508del homozygous | 5 | 2 | Â | / |
F508del heterozygous | 4 | 7 | Â | / |
Other mutations | 1 | 1 | Â | / |
FEV1 (%) | 57.8 ± 7.0 | 49.6 ± 6.4 | 0.53 | 75.2 ± 8.4 |
ΔFEV1 | 9.08 ± 2.5 | 0.07 ± 0.04 | 0.001 | / |
CRP (mg/dl) | 0.53 ± 0.16 | 8.36 ± 2.87 | 0.01 | / |
Clinical score | 7.3 ± 0.37 | 2.45 ± 0.31 | 0.001 | / |
Source of infection: | Â | Â | Â | Â |
Pseudomonas aeruginosa | 11 | 6 | Â | 3 |
Staphylococcus aureus | 3 | 3 | Â | 0 |
Burkholderia cepacia complex | 0 | 2 | Â | 0 |
Alcaligenes xilosoxidans | 0 | 1 | Â | 0 |